Back

Links between Cannabinoid Hyperemesis Syndrome symptoms and drug use, mental health problems, antisocial behavior, and personality in a national survey of adults in the United States

Hicks, B. M.; Price, A.; Goldman, P.; Ilgen, M. A.

2026-02-28 gastroenterology
10.64898/2026.02.26.26347188 medRxiv
Show abstract

BackgroundCannabinoid hyperemesis syndrome (CHS) is characterized by episodes of severe nausea, vomiting, and abdominal pain among those with heavy cannabis use. We estimated differences between those reporting CHS symptoms and other daily and less frequent cannabis users on drug use, psychiatric problems, other health problems, antisocial behavior, and personality. MethodsThe National Firearms, Alcohol, Cannabis, and Suicide survey was administered to 7034 US adults in 2025. Survey items assessed substance use, common psychiatric symptoms, personality traits, and symptoms of CHS. ResultsThose with CHS symptoms reported the highest rates and greatest variety of drug use compared to others who used cannabis. Those with CHS symptoms reported higher rates of other drug use than those who used cannabis daily without CHS symptoms across a variety of drug classes, including opioids, hallucinogens, and sedatives, higher rates of drug overdoses, and greater use of all drug classes than those with less-than-daily cannabis use. Those with CHS symptoms also reported more depression, anxiety, sleep problems, chronic pain, antisocial behavior, intimate partner violence, and disinhibited personality traits than those who used daily (mean d = 0.58) and less frequently (mean d = 0.69) and those with no cannabis use in the past 12 months (mean d = 0.99). ConclusionsThose with CHS symptoms exhibit a variety of psychological and behavioral problems including higher rates of other drug use, psychiatric symptoms, antisocial behavior, and dysfunctional personality traits. Results highlight the importance of understanding and addressing the broader psychosocial challenges faced by people experiencing CHS symptoms. Highlights O_LICHS symptoms are linked to greater polysubstance use and overdose risk C_LIO_LICHS symptoms are associated with depression, anxiety, sleep, and pain problems C_LIO_LICHS tied to antisocial behavior and intimate partner violence C_LIO_LICHS shows disinhibited personality traits and low well-being C_LIO_LINational survey identifies high-risk psychosocial CHS profile C_LI

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
American Journal of Preventive Medicine
11 papers in training set
Top 0.1%
15.1%
2
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
12.7%
3
PLOS ONE
4510 papers in training set
Top 21%
8.7%
4
Addiction Biology
47 papers in training set
Top 0.3%
3.7%
5
International Journal of Drug Policy
11 papers in training set
Top 0.1%
3.7%
6
Addiction
25 papers in training set
Top 0.2%
2.4%
7
PLOS Medicine
98 papers in training set
Top 2%
2.1%
8
JAMA Psychiatry
13 papers in training set
Top 0.2%
2.1%
50% of probability mass above
9
Scientific Reports
3102 papers in training set
Top 52%
1.9%
10
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.2%
1.9%
11
Psychopharmacology
59 papers in training set
Top 0.3%
1.9%
12
BMJ Open
554 papers in training set
Top 8%
1.8%
13
Psychological Medicine
74 papers in training set
Top 0.9%
1.8%
14
American Journal of Gastroenterology
15 papers in training set
Top 0.2%
1.7%
15
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
1.7%
16
Biomedicines
66 papers in training set
Top 1%
1.5%
17
Cureus
67 papers in training set
Top 3%
1.4%
18
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.2%
1.4%
19
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.4%
20
American Journal of Psychiatry
20 papers in training set
Top 0.2%
1.3%
21
Journal of Affective Disorders
81 papers in training set
Top 1%
1.0%
22
Translational Psychiatry
219 papers in training set
Top 3%
1.0%
23
JAMA Network Open
127 papers in training set
Top 3%
0.9%
24
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
25
Addiction Neuroscience
17 papers in training set
Top 0.4%
0.9%
26
PeerJ
261 papers in training set
Top 12%
0.9%
27
Psychiatry Research
35 papers in training set
Top 1%
0.8%
28
BMC Medicine
163 papers in training set
Top 6%
0.8%
29
Neuropsychopharmacology
134 papers in training set
Top 2%
0.8%
30
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%